Market closedNon-fractional
National Research/NRC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About National Research
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Ticker
NRC
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Providers and Services
Headquarters
Lincoln, United States
Employees
435
Website
www.nrchealth.com
NRC Metrics
BasicAdvanced
$602M
Market cap
20.31
P/E ratio
$1.24
EPS
0.47
Beta
$0.48
Dividend rate
1.90%
Dividend yield
Price and volume
Market cap
$602M
Beta
0.47
Dividend rate
$0.48
Financial strength
Current ratio
0.41
Quick ratio
0.263
Long term debt to equity
74.622
Total debt to equity
113.88
Dividend payout ratio (TTM)
119.59%
Interest coverage (TTM)
32.49%
Management effectiveness
Return on assets (TTM)
19.51%
Return on equity (TTM)
54.41%
Valuation
Price to earnings (TTM)
20.31
Price to revenue (TTM)
4.166
Price to book
16.2
Price to tangible book (TTM)
-24.26
Price to free cash flow (TTM)
23.916
Dividend yield (TTM)
1.90%
Growth
Revenue change (TTM)
-1.46%
Earnings per share change (TTM)
2.60%
3-year revenue growth (CAGR)
3.01%
3-year earnings per share growth (CAGR)
-2.76%
3-year dividend per share growth (CAGR)
58.74%
NRC Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$35M
-7.11%
Net income
$6.3M
-28.41%
Profit margin
17.84%
-22.94%
NRC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for National Research stock?
National Research (NRC) has a market cap of $602M as of July 27, 2024.
What is the P/E ratio for National Research stock?
The price to earnings (P/E) ratio for National Research (NRC) stock is 20.31 as of July 27, 2024.
Does National Research stock pay dividends?
Yes, the National Research (NRC) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.48 and the yield is 1.9%. National Research has a payout ratio of 119.59% on a trailing twelve-month basis.
When is the next National Research dividend payment date?
The next National Research (NRC) dividend payment date is unconfirmed.
What is the beta indicator for National Research?
National Research (NRC) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
![Buy or sell National Research stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell National Research stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.